Future studies should investigate whether KIF2C directly modulates Tex cell differentiation or function, and whether targeting KIF2C could reverse T cell exhaustion and enhance the efficacy of immunotherapy in osteosarcoma [63]. This evidence concerns the gene KIF2C and osteosarcoma.